Juvenile fibromyalgia: Current status of research and future developments

Nature Reviews Rheumatology

Volumn 10, Issue 2, 2014, Pages 89-96

  Kashikar Zuck, Susmita ^a   Ting, Tracy V ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; BIOMEDICAL RESEARCH; COGNITIVE THERAPY; DRUG THERAPY; EXERCISE THERAPY; FEMALE; FIBROMYALGIA; HUMANS; MALE; SELF CARE;

EID: 84895906993     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2013.177     Document Type: Review

References (119)

1. King, S. et al. The epidemiology of chronic pain in children and adolescents revisited: a systematic review. Pain 152, 2729-2738 (2011).
2. Perquin, C. W. et al. Pain in children and adolescents: a common experience. Pain 87, 51-58 (2000).
3. Mikkelsson, M., Salminen, J. J. & Kautiainen, H. Non-specific musculoskeletal pain in preadolescents. Prevalence and 1year persistence. Pain 73, 29-35 (1997).
4. Staud, R. Chronic widespread pain and fibromyalgia: two sides of the same coin? Curr. Rheumatol. Rep. 11, 433-436 (2009).
5. Buskila, D. et al. Assessment of nonarticular tenderness and prevalence of fibromyalgia in children. J. Rheumatol. 20, 368-370 (1993).
6. Clark, P., Burgos-Vargas, R., Medina-Palma, C., Lavielle, P. & Marina, F. F. Prevalence of fibromyalgia in children: A clinical study of Mexican children. J. Rheumatol. 25, 2009-2014 (1998).
7. Gerloni, V., Ghirardini, M. & Fantini, F. Assessment of nonarticular tenderness and prevalence of primary fibromyalgia syndrome in healthy Italian schoolchildren [abstract]. Arthritis Rheum. 41, 1405 (1998).
8. Gare, B. A. Epidemiology of rheumatic disease in children. Curr. Opin. Rheumatol. 8, 449-454 (1996).
9. Siegel, D. M., Janeway, D. & Baum, J. Fibromyalgia syndrome in children and adolescents: clinical features at presentation and status at follow-up. Pediatrics 101, 377-382 (1998).
10. Yunus, M. B. & Masi, A. T. Juvenile primary fibromyalgia syndrome. A clinical study of thirty-three patients and matched normal controls. Arthritis Rheum. 28, 138-145 (1985).
11. Wolfe et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum. 33, 160-172 (1990).
12. Mikkelsson, M., Sourander, A., Piha, J. & Salminen, J. J. Psychiatric symptoms in preadolescents with musculoskeletal pain and fibromyalgia. Pediatrics 100, 220-227 (1997).
13. Reid, G. J., Lang, B. A. & McGrath, P. J. Primary juvenile fibromyalgia: psychological adjustment, family functioning, coping, and functional disability. Arthritis Rheum. 40, 752-760 (1997).
14. Staud, R., Price, D. D. & Robinson, M. E. The provisional diagnostic criteria for fibromyalgia: one step forward, two steps back: comment on the article by Wolfe et al. Arthritis Care Res. (Hoboken) 62, 1675-1676 (2010).
15. Vanderschueren, S., Van Wambeke, P. & Morlion, B. Fibromyalgia: do not give up the tender point count too easily: comment on the article by Wolfe et al. Arthritis Care Res. (Hoboken) 62, 1675 (2010).
16. Zernikow, B. et al. Definition, diagnosis and therapy of chronic widespread pain and so-called fibromyalgia syndrome in children and adolescents. Systematic literature review and guideline. Schmerz. 26, 318-330 (2012).
17. Swain, N. F., Kashikar-Zuck, S., Brent Graham, T. & Prahalad, S. Tender point assessment in juvenile primary fibromyalgia syndrome. Arthritis Rheum. 53, 785-787 (2005).
18. American Pain Society. Assessment and management of children with chronic pain. A position statement from the American Pain Society. American Pain Society [online], http://www.americanpainsociety.org/uploads/pdfs/aps12-pcp.pdf (2012).
19. The Mayday Fund. A Call to Revolutionize Chronic Pain Care in America: An Opportunity in Health Care Reform [online], http://www.maydaypainreport.org/ (2009).
20. Kashikar-Zuck, S., Graham, T. B., Huenefeld, M. D. & Powers, S. W. A review of biobehavioral research in juvenile primary fibromyalgia syndrome. Arthritis Care Res. (Hoboken) 13, 388-397 (2000).
21. Wolfe, F. et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. (Hoboken) 62, 600-610 (2010).
22. Kashikar-Zuck, S. et al. Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trial. Arthritis Rheum. 64, 297-305 (2012).
23. Uziel, Y., Chapnick, G., Jaber, L., Nemet, D. & Hashkes, P. J. Five-year outcome of children with "growing pains": correlations with pain threshold. J. Pediatr. 156, 838-840 (2010).
24. Viswanathan, V. & Khubchandani, R. P. Joint hypermobility and growing pains in school children. Clin. Exp. Rheumatol. 26, 962-966 (2008).
25. Gedalia, A., Press, J., Klein, M. & Buskila, D. Joint hypermobility and fibromyalgia in schoolchildren. Ann. Rheum. Dis. 52, 494-496 (1993).
26. Ting, T. V. et al. The role of benign joint hypermobility in the pain experience in juvenile fibromyalgia: an observational study. Pediatr. Rheumatol. Online J. 10, 16 (2012).
27. Hashkes, P. J. et al. Decreased pain threshold in children with growing pains. J. Rheumatol. 31, 610-613 (2004).
28. Uziel, Y. & Hashkes, P. J. Growing pains in children. Pediatr. Rheumatol. Online J. 5, 5 (2007).
29. Buskila, D. et al. Fibromyalgia syndrome in children: an outcome study. J. Rheumatol. 22, 525-528 (1995).
30. Mikkelsson, M. One year outcome of preadolescents with fibromyalgia. J. Rheumatol. 26, 674-682 (1999).
31. Gedalia, A., Garcia, C. O., Molina, J. F., Bradford, N. J. & Espinoza, L. R. Fibromyalgia syndrome: experience in a pediatric rheumatology clinic. Clin. Exp. Rheumat. 18, 415-419 (2000).
32. Kashikar-Zuck, S. et al. Controlled follow-up study of physical and psychosocial functioning of adolescents with juvenile primary fibromyalgia syndrome. Rheumatology (Oxford) 49, 2204-2209 (2010).
33. Apkarian, A. V., Bushnell, M. C., Treede, R. D. & Zubieta, J. K. Human brain mechanisms of pain perception and regulation in health and disease. Eur. J. Pain 9, 463-484 (2005).
34. Treede, R. D., Kenshalo, D. R., Gracely, R. H. & Jones, A. K. The cortical representation of pain. Pain 79, 105-111 (1999).
35. Julien, N., Goffaux, P., Arsenault, P. & Marchand, S. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114, 295-302 (2005).
36. Staud, R. Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions. Expert Rev. Neurother. 12, 577-585 (2012).
37. Mason, P. Ventromedial medulla: pain modulation and beyond. J. Comp. Neurol. 493, 2-8 (2005).
38. Gracely, R. H., Petzke, F., Wolf, J. M. & Clauw, D. J. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum. 46, 1333-1343 (2002).
39. Williams, D. A. & Gracely, R. H. Functional magnetic resonance imaging findings in fibromyalgia. Arthritis Res. Ther. 8, 224 (2006).
40. Latremoliere, A. & Woolf, C. J. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J. Pain 10, 895-926 (2009).
41. Staud, R., Craggs, J. G., Robinson, M. E., Perlstein, W. M. & Price, D. D. Brain activity related to temporal summation of Cfiber evoked pain. Pain 129, 130-142 (2007).
42. Staud, R., Price, D. D., Robinson, M. E., Mauderli, A. P. & Vierck, C. J. Maintenance of windup of second pain requires less frequent stimulation in fibromyalgia patients compared to normal controls. Pain 110, 689-696 (2004).
43. Woolf, C. Central sensitization: implications for the diagnosis and treatment of pain. Pain 152, S2-S15 (2011).
44. Russell, I. J. et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 37, 1593-1601 (1994).
45. Schwarz, M. J. et al. Relationship of substance P, 5hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients. Neurosci. Lett. 259, 196-198 (1999).
46. Harris, R. E. et al. Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum. 60, 3146-3152 (2009).
47. Valdes, M. et al. Increased glutamate/glutamine compounds in the brains of patients with fibromyalgia: a magnetic resonance spectroscopy study. Arthritis Rheum. 62, 1829-1836 (2010).
48. Russell, I. J. et al. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J. Rheumatol. 19, 104-109 (1992).
49. Russell, I. J., Vaeroy, H., Javors, M. & Nyberg, F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum. 35, 550-556 (1992).
50. Giovengo, S. L., Russell, I. J. & Larson, A. A. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J. Rheumatol. 26, 1564-1569 (1999).
51. Wood, P. B., Glabus, M. F., Simpson, R. & Patterson, J. C., 2nd. Changes in gray matter density in fibromyalgia: correlation with dopamine metabolism. J. Pain 10, 609-618 (2009).
52. Wood, P. B. et al. Fibromyalgia patients show an abnormal dopamine response to pain. Eur. J. Neurosci. 25, 3576-3582 (2007).
53. Crofford, L. J. et al. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav. Immun. 18, 314-325 (2004).
54. Griep, E. N., Boersma, J. W. & de Kloet, E. R. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J. Rheumatol. 20, 469-474 (1993).
55. Dinser, R., Halama, T. & Hoffmann, A. Stringent endocrinological testing reveals subnormal growth hormone secretion in some patients with fibromyalgia syndrome but rarely severe growth hormone deficiency. J. Rheumatol. 27, 2482-2488 (2000).
56. Jones, K. D., Deodhar, P., Lorentzen, A., Bennett, R. M. & Deodhar, A. A. Growth hormone perturbations in fibromyalgia: a review. Semin. Arthritis Rheum. 36, 357-379 (2007).
57. Feng, J. et al. Discovery of potential new gene variants and inflammatory cytokine associations with fibromyalgia syndrome by whole exome sequencing. PLoS ONE 8, e65033 (2013).
58. Uceyler, N. et al. Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum. 54, 2656-2664 (2006).
59. Bazzichi, L. et al. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin. Exp. Rheumatol. 25, 225-230 (2007).
60. Gur, A. et al. Cytokines and depression in cases with fibromyalgia. J. Rheumatol. 29, 358-361 (2002).
61. Maes, M. et al. The immune-inflammatory pathophysiology of fibromyalgia: increased serum soluble gp130, the common signal transducer protein of various neurotrophic cytokines. Psychoneuroendocrinology 24, 371-383 (1999).
62. Wang, H., Moser, M., Schiltenwolf, M. & Buchner, M. Circulating cytokine levels compared to pain in patients with fibromyalgia - a prospective longitudinal study over 6 months. J. Rheumatol. 35, 1366-1370 (2008).
63. Yigit, S., Inanir, A., Tekcan, A., Inanir, S., Tural, S. & Ates, O. Association between fibromyalgia syndrome and polymorphism of the IL4 gene in a Turkish population. Gene 527, 62-64 (2013).
64. Schanberg, L. E., Keefe, F. J., Lefebvre, J. C., Kredich, D. W. & Gil, K. M. Social context of pain in children with juvenile primary fibromyalgia syndrome: parental pain history and family environment. Clin. J. Pain 14, 107-115 (1998).
65. Wolfe, F., Ross, K., Anderson, J., Russell, I. J. & Hebert, L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 38, 19-28 (1995).
66. Buskila, D., Neumann, L., Alhoashle, A. & AbuShakra, M. Fibromyalgia syndrome in men. Semin. Arthritis Rheum. 30, 47-51 (2000).
67. Yunus, M. B., Inanici, F., Aldag, J. C. & Mangold, R. F. Fibromyalgia in men: comparison of clinical features with women. J. Rheumatol. 27, 485-490 (2000).
68. Arnold, L. M. et al. Family study of fibromyalgia. Arthritis Rheum. 50, 944-952 (2004).
69. Buskila, D. & Neumann, L. Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM. J. Rheumatol. 24, 941-944 (1997).
70. Buskila, D., Neumann, L., Hazanov, I. & Carmi, R. Familial aggregation in the fibromyalgia syndrome. Semin. Arthritis Rheum. 26, 605-611 (1996).
71. Burda, C. D., Cox, F. R. & Osborne, P. Histocompatability antigens in the fibrositis (fibromyalgia) syndrome. Clin. Exp. Rheumatol. 4, 355-358 (1986).
72. Yunus, M. B. et al. Genetic linkage analysis of multicase families with fibromyalgia syndrome. J. Rheumatol. 26, 408-412 (1999).
73. Cohen, H., Buskila, D., Neumann, L. & Ebstein, R. P. Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum. 46, 845-847 (2002).
74. Offenbaecher, M. et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum. 42, 2482-2488 (1999).
75. Buskila, D., Cohen, H., Neumann, L. & Ebstein, R. P. An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits. Mol. Psychiatry 9, 730-731 (2004).
76. Malt, E. A., Olafsson, S., Aakvaag, A., Lund, A. & Ursin, H. Altered dopamine D2 receptor function in fibromyalgia patients: a neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls. J. Affect. Disord. 75, 77-82 (2003).
77. Gursoy, S. et al. Significance of catecholOmethyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol. Int. 23, 104-107 (2003).
78. Mikkelsson, M., Kaprio, J., Salminen, J. J., Pulkkinen, L. & Rose, R. J. Widespread pain among 11yearold Finnish twin pairs. Arthritis Rheum. 44, 481-485 (2001).
79. Kashikar-Zuck, S. et al. Anxiety and depressive symptoms in adolescents with juvenile fibromyalgia and their mothers. J. Pain 6, 31 (2005).
80. Kashikar-Zuck, S., Vaught, M. H., Goldschneider, K. R., Graham, T. B. & Miller, J. C. Depression, coping and functional disability in juvenile primary fibromyalgia syndrome. J. Pain 3, 412-419 (2002).
81. Joffe, N. E. et al. The utility of the PedsQL Rheumatology Module as an outcome measure in juvenile fibromyalgia. Arthritis Care Res. (Hoboken) http://dx.doi.org/1002/acr.22
82. Kashikar-Zuck, S. et al. Quality of life and emotional functioning in youth with chronic migraine and juvenile fibromyalgia. Clin. J. Pain 29, 1066-1072 (2013).
83. Varni, J. W., Burwinkle, T. M., Limbers, C. A. & Szer, I. S. The PedsQL as a patient-reported outcome in children and adolescents with fibromyalgia: an analysis of OMERACT domains. Health Qual. Life Outcomes 5, 9 (2007).
84. Kashikar-Zuck, S. et al. Actigraphy-based physical activity monitoring in adolescents with juvenile primary fibromyalgia syndrome. J. Pain 11, 885-893 (2010).
85. Kashikar-Zuck, S. et al. Relationship between school absenteeism and depressive symptoms among adolescents with juvenile fibromyalgia. J. Pediatr. Psychol. 35, 996-1004 (2010).
86. Kashikar-Zuck, S. et al. Social functioning and peer relationships of adolescents with juvenile fibromyalgia syndrome. Arthritis Rheum. 57, 474-480 (2007).
87. Kashikar-Zuck, S. et al. Anxiety, mood, and behavioral disorders among pediatric patients with juvenile fibromyalgia syndrome. Clin. J. Pain 24, 620-626 (2008).
88. Arnold, L. M. et al. Comorbidity of fibromyalgia and psychiatric disorders. J. Clin. Psychiatry 67, 1219-1225 (2006).
89. Schanberg, L. E. et al. Family pain history predicts child health status in children with chronic rheumatic disease. Pediatrics 108, E47 (2001).
90. Kashikar-Zuck, S. et al. Family factors, emotional functioning, and functional impairment in juvenile fibromyalgia syndrome. Arthritis Rheum. 59, 1392-1398 (2008).
91. Sil, S. et al. Influence of family environment on long-term psychosocial functioning of adolescents with juvenile fibromyalgia. Arthritis Care Res. (Hoboken) 65, 903-909 (2013).
92. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01237587?term=NCT01237587&rank=1 (2013).
93. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01020474?term=NCT01020474&rank=1 (2013).
94. Arnold, L. M., Gendreau, R. M., Palmer, R. H., Gendreau, J. F .& Wang, Y. Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 62, 2745-2756 (2010).
95. Arnold, L. M. et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 50, 2974-2984 (2004).
96. Häuser, W., Urrútia, G., Tort, S., Üçeyler, N. & Walitt, B. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database of Systematic Reviews, Issue Art. No.: CD010 http://dx.doi.org/1002/14651CD010
97. Crofford, L. J.et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 52, 1264-1273 (2005).
98. Dooley, D. J., Taylor, C. P., Donevan, S. & Feltner, D. Ca2+ channel α2δ ligands: novel modulators of neurotransmission. Trends Pharmacol. Sci. 28, 75-82 (2007).
99. Arnold, L. M et al. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am. J. Med. 112, 191-197 (2002).
100. Norregaard, J., Volkmann, H. & DanneskioldSamsoe, B. A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain 61, 445-449 (1995).
101. Patkar, A. A. et al. A randomized, controlled, trial of controlled release paroxetine in fibromyalgia. Am. J. Med. 120, 448-454 (2007).
102. Wolfe, F., Cathey, M. A. & Hawley, D. J. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand. J. Rheumatol. 23, 255-259 (1994).
103. Bennett, R. M., Kamin, M., Karim, R. & Rosenthal, N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am. J. Med. 114, 537-545 (2003).
104. Eccleston, C. et al. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database of Systematic Reviews, Issue Art. No.:CD003968 http://dx.doi.org/1002/14651CD003pub
105. Palermo, T. M., Eccleston, C., Lewandowski, A. S., Williams, A. C. & Morley, S. Randomized controlled trials of psychological therapies for management of chronic pain in children and adolescents: an updated meta-analytic review. Pain 148, 387-397 (2010).
106. Degotardi, P. J. et al. Development and evaluation of a cognitive-behavioral intervention for juvenile fibromyalgia. J. Pediatr. Psychol. 31, 714-723 (2006).
107. Kashikar-Zuck, S., Swain, N. F., Jones, B. A. & Graham, T. B. Efficacy of cognitive-behavioral intervention for juvenile primary fibromyalgia syndrome. J. Rheumatol. 32, 1594-1602 (2005).
108. Palermo, T. M., Wilson, A. C., Peters, M., Lewandowski, A. & Somhegyi, H. Randomized controlled trial of an Internet-delivered family cognitive-behavioral therapy intervention for children and adolescents with chronic pain. Pain 146, 205-213 (2009).
109. Stinson, J. N. et al. An internet-based self-management program with telephone support for adolescents with arthritis: a pilot randomized controlled trial. J. Rheumatol. 37, 1944-1952 (2010).
110. Hauser, W. et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res. Ther. 12, R79 (2010).
111. Hooten, W. M., Qu, W., Townsend, C. O. & Judd, J. W. Effects of strength vs aerobic exercise on pain severity in adults with fibromyalgia: a randomized equivalence trial. Pain 153, 915-923 (2012).
112. van Koulil, S. et al. Cognitive-behavioural therapies and exercise programmes for patients with fibromyalgia: state of the art and future directions. Ann. Rheum. Dis. 66, 571-581 (2007).
113. Jones, K. D., Adams, D., Winters-Stone, K. & Burckhardt, C. S. A comprehensive review of 46 exercise treatment studies in fibromyalgia (1988-2005). Health Qual. Life Outcomes 4, 67 (2006).
114. American Pain Society. Guideline for the management of fibromyalgia syndrome pain in adults and children. American Pain Society [online], http://apps.americanpainsociety.org/Default.aspx?TabID=251&ProductId=473 (2005).
115. Stephens, S. et al. Feasibility and effectiveness of an aerobic exercise program in children with fibromyalgia: results of a randomized controlled pilot trial. Arthritis Rheum. 59, 1399-1406 (2008).
116. Sil, S. et al. Evidence of physical deconditioning in adolescents with juvenile fibromyalgia: deficiencies in strength and balance. J. Pain 14, S3 (2013).
117. Jones, K., King, L., Mist, S., Bennett, R. & Horak, F. Postural control deficits in people with fibromyalgia: a pilot study. Arthritis Res. Ther. 13, R127 (2011).
118. Jones, K. D., Horak, F. B., Winters-Stone, K., Irvine, J. M. & Bennett, R. M. Fibromyalgia is associated with impaired balance and falls. J. Clin. Rheumatol. 15, 16-21 (2009).
119. Thomas, S. M., Sil, S., Kashikar-Zuck, S. & Myer, G. D. Can modified neuromuscular training support the treatment of chronic pain in adolescents? Strength Cond. J. 35, 12-26 (2013).